Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2005-004163-39Phase 3Active
Phase 3, single-arm trial of pioglitazone in polycystic ovary syndrome (PCOS), sponsored by Sant Joan de Déu Hospital. Primary endpoints: Endocrine-metabolic profile, Body composition and 2 more. Started Oct 2005; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2005-004163-39.